Showing results (181-190 of 343) with videos related to

Sort By:
Pageof 35
Blood|January 11, 2007
Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocolMarco Vignetti, Paola Fazi, Giuseppe Cimino, et al.
Clinical Case Reports|July 20, 2023
A case of high-risk AML in a patient with advanced systemic mastocytosisManlio Fazio, Calogero Vetro, Uroš Markovic, et al.
Nutrients|October 6, 2016
Antiproliferative and Antiangiogenic Effects of Punica granatum Juice (PGJ) in Multiple Myeloma (MM)Daniele Tibullo, Nunzia Caporarello, Cesarina Giallongo, et al.
Antioxidants (Basel, Switzerland)|April 23, 2022
TLR4 Signaling and Heme Oxygenase-1/Carbon Monoxide Pathway Crosstalk Induces Resiliency of Myeloma Plasma Cells to Bortezomib TreatmentGrazia Scandura, Cesarina Giallongo, Fabrizio Puglisi, et al.
Haematologica|March 15, 2006
The role of BCR/ABL isoforms in the presentation and outcome of patients with Philadelphia-positive acute lymphoblastic leukemia: a seven-year update of the GIMEMA 0496 trialGiuseppe Cimino, Fabrizio Pane, Loredana Elia, et al.
Haematologica|April 10, 2002
Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myelomaPatrizia Tosi, Elena Zamagni, Claudia Cellini, et al.
Cancers|July 26, 2020
Inhibition of TLR4 Signaling Affects Mitochondrial Fitness and Overcomes Bortezomib Resistance in Myeloma Plasma CellsCesarina Giallongo, Daniele Tibullo, Fabrizio Puglisi, et al.
Frontiers in Oncology|March 6, 2019
Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53Elena Tirrò, Michele Massimino, Chiara Romano, et al.
Cancers|April 14, 2026
FcγRIIIA Genotype in Plasma Cell Dyscrasias Is Associated with Clinical Progression, Bone Disease Extension and Immune DysfunctionDaniela Cambria, Maria Teresa Cannizzaro, Nunziatina Laura Parrinello, et al.
Critical Reviews in Oncology/Hematology|July 2, 2011
Primary plasma cell leukemia in the era of new drugs: has something changed?Pellegrino Musto, Livio Pagano, Maria Teresa Petrucci, et al.
Pageof 35